Arcutis Biotherapeutics Announces Proposed Public Offering and Concurrent Private Placement of Common Stock
WESTLAKE VILLAGE, Calif., Sept. 29, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on […]